Rainier Acquisition Corporation Separates Class A Shares and Warrants

NEW YORK, NY, Sept. 11, 2026 /CourierPR/ -- Rainier Acquisition Corporation, a special purpose acquisition company (SPAC) focused on the global life sciences industries, announced on August 27, 2026, that its Class A ordinary shares and warrants will separate from its units on September 14, 2026. This separation will allow unit holders to trade the shares and warrants independently, starting on September 15, 2026, on the Nasdaq Capital Market.

Each unit, sold in the company’s initial public offering (IPO), consists of one Class A ordinary share and one-quarter of one redeemable warrant. Upon separation, only whole warrants will trade, with no fractional warrants issued. Each whole warrant entitles the holder to purchase one Class A ordinary share at a price of $11.50 per share, subject to certain adjustments. Only whole warrants will be exercisable.

The separation process will enable investors to trade the Class A ordinary shares and warrants independently, potentially offering more flexibility in their investment strategies. The units began trading on Nasdaq on August 27, 2026, and the initial public offering, including the full exercise of the underwriter’s over-allotment option, raised $86,250,000. Chardan Capital Markets LLC acted as the sole book-running manager for the offering.

Rainier Acquisition Corporation is led by Gbola Amusa, MD, CFA, as Chief Executive Officer, and Guy Barudin as Chief Financial Officer. The company’s primary focus is on the global life sciences industries, including therapeutics, diagnostics, genomics, precision medicine, life science tools, research services, biomanufacturing, and related subsectors. The separation of the Class A ordinary shares and warrants is part of the company’s ongoing efforts to provide more flexibility to its shareholders.

The separation process requires unit holders to contact Continental Stock Transfer & Trust Company, the company’s transfer agent, to separate their units into Class A ordinary shares and warrants.

This move by Rainier Acquisition Corporation is part of its strategy to enhance the liquidity and flexibility of its shares and warrants, potentially benefiting investors looking to diversify their holdings or focus on specific aspects of the company’s business. The company’s management believes that this separation will provide greater transparency and flexibility to its shareholders, aligning with its mission to drive value creation in the global life sciences sector.